Quick Answer
Century Therapeutics, Inc. reported Stockholders Equity of $158.94 million for fiscal year 2025.
Century Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $158.94M | -1.5% |
| 2024 | $161.36M | -12.7% |
| 2023 | $184.75M | -39.0% |
| 2022 | $302.74M | -23.6% |
| 2021 | $396.24M | +472.4% |
| 2020 | -$106.41M | -15.8% |
| 2019 | -$91.86M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $176.35M | -9.9% | -16.0% |
| June 30, 2025 | $209.90M | -5.5% | -12.7% |
| March 31, 2025 | $240.44M | +35.2% | +49.0% |
| December 31, 2024 | $161.36M | -12.7% | -17.5% |
| September 30, 2024 | $195.69M | -10.7% | -11.9% |
| June 30, 2024 | $222.10M | -10.3% | +24.9% |
| March 31, 2024 | $177.88M | -35.8% | -3.7% |
| December 31, 2023 | $184.75M | -39.0% | -15.7% |
- Century Therapeutics, Inc. showed a decrease of -1.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Century Therapeutics, Inc.’s stockholders equity has grown by 273.0% (from -$91.86 million to $158.94 million).
- The most recent figure is from Century Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: